VSQM
NVO

V-Square Quantitative Management’s Novo Nordisk NVO Stock Holding History

V-Square Quantitative Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Sell
8,334
-1,280
-13% -$55K 0.04% 383
2026
Q1 		$353K Buy
9,614
+1,627
+20% +$77.1K 0.04% 395
2025
Q4 		$406K Buy
+7,987
New +$408K 0.04% 341
2025
Q3 		– Sell
-7,627
Closed -$526K – 445
2025
Q2 		$526K Sell
7,627
-2,027
-21% -$138K 0.07% 289
2025
Q1 		$670K Hold
9,654
– – 0.1% 228
2024
Q4 		$851K Buy
9,654
+2,374
+33% +$257K 0.12% 175
2024
Q3 		$867K Hold
7,280
– – 0.13% 168
2024
Q2 		$1.06M Buy
7,280
+361
+5% +$47.8K 0.17% 109
2024
Q1 		$881K Hold
6,919
– – 0.12% 138
2023
Q4 		$716K Buy
+6,919
New +$684K 0.13% 133

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

V-Square Quantitative Management's NVO Position: Q2 2026 in Review

V-Square Quantitative Management reduced its Novo Nordisk (NVO) stake by 13% in Q2 2026, selling an estimated $55K and leaving 8,334 shares worth $400K. The position accounts for 0.04% of the portfolio, ranked #383.

V-Square Quantitative Management first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.06M in Q2 2024. 530 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • V-Square Quantitative Management held 8,334 shares of Novo Nordisk worth $400K as of Q2 2026.
  • V-Square Quantitative Management sold 1,280 Novo Nordisk shares in Q2 2026, an estimated $55K.
  • Novo Nordisk made up 0.04% of V-Square Quantitative Management's portfolio in Q2 2026, its #383 holding.
  • V-Square Quantitative Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • V-Square Quantitative Management's Novo Nordisk position peaked at $1.06M in Q2 2024.
  • 530 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.